MedPath

Presbyopia-Correcting Intraocular Lenses (IOLs)

Phase 4
Completed
Conditions
Cataract
Registration Number
NCT00963560
Lead Sponsor
Alcon Research
Brief Summary

The purpose of this study is to prospectively evaluate postoperative visual and refractive parameters in a series of subjects bilaterally implanted with Presbyopia-Correcting Intraocular Lenses (IOLs).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
132
Inclusion Criteria
  • diagnosed with bilateral cataracts
  • candidate for presbyopic lens
Exclusion Criteria
  • > 1 Diopter preoperative astigmatism by Keratometry readings
  • pre-existing conditions that could skew the results

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Best Corrected Visual Acuity6 Months after surgery

Best corrected vision was tested at 4 meters (m), 60 centimeters (cm), 40cm and at preferred distance (distance chosen by each subject) with a standard ETDRS chart for distance and a hand held chart for near. Scores were calculated using logMAR values. LogMAR is the "logarithm of the minimum angle of resolution". A lower logMAR value indicates better visual acuity. Preferred distance for each study group was as follows: ReSTOR +3 = 38.7 +/- 6.8 cm, Crystalens HD = 49.9 +/- 9.8 cm, Crystalens AO = 53.1 +/- 9.8 cm.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Contact Alcon Call Center For Trial Locations

🇺🇸

Fort Worth, Texas, United States

Contact Alcon Call Center For Trial Locations
🇺🇸Fort Worth, Texas, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.